EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Diagnostic reversion in dementia care: A real‐world analysis of mild cognitive impairment diagnoses after dementia in a large electronic medical record system

Diagnostic reversion in dementia care: Eine Real-World-Analyse von Diagnosen einer leichten kognitiven Beeinträchtigung nach Demenz in einem großen elektronischen Krankenaktensystem

Silvia Miramontes iD, Umair Khan, Scott Zimmerman, Erin L Ferguson, Hunter Mills, Boris Oskotsky, Evan Phelps, Tomiko T Oskotsky, John A Capra, M Maria Glymour, Marina Sirota, Elena Tsoy

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-10 · 18 (4)

DOI: 10.1002/dad2.70523 ↗

Auf einen Blick

Bei 5965 Patient:innen mit inzidenter Demenz trat bei 13,7 % später eine MCI-Diagnose auf. Höheres Alter war mit geringeren, Spanisch als Sprache mit höheren Odds für Reversion verbunden.

Fragestellung

Wie häufig tritt „diagnostic reversion“ auf, also eine MCI-Diagnose nach einer Demenzdiagnose, und welche Faktoren sagen dies voraus?

Methode

Analyse von 5965 Patient:innen ab 50 Jahren mit inzidenter Demenz aus UCSF-Elektronischen Gesundheitsakten; Prädiktoren mit logistischer Regression und Random Forest.

Ergebnisse

Reversion trat bei 13,7 % auf. Geringere Odds bei älteren Erwachsenen (OR 0,95/Jahr; 95 %-KI 0,92–0,98), höhere bei Spanischsprachigen (OR 2,26; 95 %-KI 1,28–4,00), höherem kardiovaskulären Risiko (OR 1,16; 95 %-KI 1,01–1,33) und höherem Charlson-Index (OR 1,09; 95 %-KI 1,05–1,14).

Schlussfolgerung der Autor:innen

Diagnostic reversion ist häufig und sozial geprägt; dies spricht für Beiträge von Fehldiagnosen, klinischer Unsicherheit oder Variabilität in Präsentation und Versorgungskontext.

Kernaussagen

  • MCI nach Demenz trat bei 13,7 % der Patient:innen auf
  • Älteres Alter war mit geringeren Odds verbunden
  • Spanischsprachige hatten höhere Odds für Reversion

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published online on 2026-11-01. Written by Silvia Miramontes and 11 co-authors. Institution: Bakar Computational Health Sciences Institute University of California, San Francisco San Francisco California USA. 52 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIA NIH HHS, National Institute on Aging.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

INTRODUCTION If mild cognitive impairment (MCI) is diagnosed after dementia, it suggests either the dementia diagnosis was premature, or the MCI diagnosis is incorrect. We investigated the prevalence and predictors of such “diagnostic reversion”—MCI after dementia—in a large health system. METHODS Among 5965 patients aged 50+ with incident dementia in University of California San Francisco electronic health records, we identified “reverters” with a subsequent MCI diagnosis. We used group least absolute shrinkage and selection operator–regularized logistic regression and random forest models to identify predictors. RESULTS Reversion occurred in 13.7% of patients. Lower odds were observed among older adults (odds ratio [OR] = 0.95/year; 95% confidence interval [CI]: 0.92–0.98), while higher odds were found among Spanish speakers (OR = 2.26; 95% CI: 1.28–4.00), those with greater cardiovascular risk (OR = 1.16; 95% CI: 1.01–1.33), and higher Charlson Comorbidity Index burden (OR = 1.09; 95% CI: 1.05–1.14). DISCUSSION Diagnostic reversion is common and socially patterned, suggesting contributions from misdiagnosis, clinical uncertainty, or variability in clinical presentation and care setting.

Subjects

Author keywords

cardiovascular riskdementiadiagnostic reversiondiagnostic trajectorieselectronic health recordshealth disparitieslanguage barriersmild cognitive impairmentmisdiagnosisreal‐world datareal‐world evidencesocial determinants of health

Authors and institutions

  • Bakar Computational Health Sciences Institute University of California, San Francisco San Francisco California USA.
  • Department of Epidemiology Boston University School of Public Health Boston Massachusetts USA.
  • Department of Epidemiology and Biostatistics University of California, San Francisco San Francisco California USA.
  • Academic Research Services University of California San Francisco California USA.
  • Department of Pediatrics and Medicine University of California, San Francisco San Francisco California USA.
  • Global Brain Health Institute University of California, San Francisco San Francisco California USA.

ORCID profiles: Silvia Miramontes

Funding

  • NIA NIH HHS
  • National Institute on Aging

Cite

APA

Miramontes, S., Khan, U., Zimmerman, S., Ferguson, E. L., Mills, H., Oskotsky, B., Phelps, E., Oskotsky, T. T., Capra, J. A., Glymour, M. M., Sirota, M., & Tsoy, E. (2026). Diagnostic reversion in dementia care: A real‐world analysis of mild cognitive impairment diagnoses after dementia in a large electronic medical record system. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(4). https://doi.org/10.1002/dad2.70523

Vancouver

Miramontes S, Khan U, Zimmerman S, Ferguson EL, Mills H, Oskotsky B, et al. Diagnostic reversion in dementia care: A real‐world analysis of mild cognitive impairment diagnoses after dementia in a large electronic medical record system. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(4). doi:10.1002/dad2.70523

BibTeX
@article{Miramontes2026,
  author = {Miramontes, Silvia and Khan, Umair and Zimmerman, Scott and Ferguson, Erin L and Mills, Hunter and Oskotsky, Boris and Phelps, Evan and Oskotsky, Tomiko T and Capra, John A and Glymour, M Maria and Sirota, Marina and Tsoy, Elena},
  title = {Diagnostic reversion in dementia care: A real‐world analysis of mild cognitive impairment diagnoses after dementia in a large electronic medical record system},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {4},
  doi = {10.1002/dad2.70523}
}
Start for free →